logo
My nephew's life was put on hold by Long Covid

My nephew's life was put on hold by Long Covid

Long Covid cuts a swathe through the lives of children and adults alike, and the numbers affected are staggering. In Scotland alone, there are estimated to be over 185,000 people with this disease, living with debilitating symptoms like crushing fatigue, brain fog, digestive problems, breathing difficulties and muscle weakness.
My lovely nephew is one of those people. He was an energetic student in his final year at Glasgow University when he caught Covid-19 aged 22 and has been laid low by Long Covid since. He was full of plans, to work and travel, but instead, had to give up his job and move back in with his parents.
Read More:
It's been like watching someone being drugged and restrained. His body cries out for sleep but rest doesn't refresh him. He could sleep for 10 hours and still wake up feeling shattered. Most days since being infected, he has had a painful upset stomach. Like other people with Long Covid, he has bad days and better days, but can never predict what's coming. Some days he can do things, others he can barely hold a conversation.
All that is bad enough, but what compounds the distress is the lack of meaningful support. To say that NHS support services are inadequate to meet people's needs would be a laughable understatement. My nephew's experience of GPs he has seen is that he knows more about Long Covid than they do. In fact he puts it more bluntly than that: 'Most don't have a clue.' In spite of ministers' insistence that there are clear referral pathways for people with Long Covid in Scotland, reports by the ALLIANCE and Chest, Heart and Stroke Scotland show that the overwhelming majority of people struggle to get the support they need – a finding that is borne out by members of Long Covid Scotland.
Again and again, people report having to research treatments themselves or turn to private GPs to get help that is not offered on the NHS – that's if they can afford it. As my nephew puts it, people feel 'abandoned' and have to figure out the way forward for themselves.
The inadequacy of NHS support services has been the focus of campaigning by charities Long Covid Scotland and Long Covid Kids since they were set up, but they are at the end of their tether. This week, in protest at the Scottish Government's inaction, the two organisations formally resigned from the Scotland's Long Covid Strategic Network, which reports to the Scottish Government.
They are exasperated and angry that after announcing a £4.5m one-year, non-recurring fund for people with Long Covid, ME, and chronic fatigue in December, ministers have yet to allocate a penny of it, and that this comes after years in which a previous £10m failed to deliver proper support for people with Long Covid.
Trust has broken down. 'What was framed as a hopeful investment now stands as a symbol of inaction and broken promises,' says Jane Ormerod, the chair of Long Covid Scotland.
The charities' verdict is withering. Instead of support being ramped up, they state that some services are being decommissioned, with still no provision at all for children and young people in most areas. They say that people with lived experience of Long Covid have consistently seen their input sidelined and that most health boards have disengaged from the network but the government hasn't intervened.
They state: 'The Scottish Government remains functionally absent from the network: no oversight, no leadership, and no enforcement of its own Long Covid Service policy requirements.
'Faith has been lost.
'Too many times we have listened to assurances within the network followed by inaction.' Scots with Long Covid, they say, have been 'repeatedly let down'.
That they've run out of patience is entirely understandable. A Holyrood Committee inquiry two years ago found that 'almost all individual respondents to the call for views spoke of a lack of awareness among medical professionals, GPs in particular, in terms of assessing patients, diagnosing long Covid and providing treatment options'.
People told the Holyrood committee they had been 'gaslighted' and struggled to get their experience taken seriously.
This just shouldn't happen, given the strong the international evidence that exists on Long Covid and how it presents.
Research into Long Covid is ongoing, and no one expects a miracle cure, but the dim understanding of it among many medical professionals, the lack of clear treatment pathways for many sufferers and the history of broken promises, fall well short of what people have a right to expect. The effect of it all is that many people in the grip of a life-changing illness are being left without meaningful medical care.
The Public Health Minister Jenni Minto says she regrets the charities' departure from the Long Covid network and that ministers are working with NHS Boards, preparing to set out how the £4.5m will be spent. But the charities have no faith in government promises.
Perhaps the saddest aspect of all this is the experience of children and young people. Helen Goss, the Scottish lead for Long Covid Kids, says the system 'continues to fail the very people it was created to support'. The charities quote an 11-year-old with Long Covid in Edinburgh, who says: "I have nothing, no health, no fun, no life. No one seems to care.'
Four years on from the height of the pandemic, the lack of meaningful support for children and adults with Long Covid is hard to excuse. The Scottish Government promises action – again – but for those living with this every day, it's way too late.
Rebecca McQuillan is a journalist specialising in politics and Scottish affairs. She can be found on Bluesky at @becmcq.bsky.social and on X at @BecMcQ
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

'My seatbelt saved my life - but I wasn't even involved in a car crash'
'My seatbelt saved my life - but I wasn't even involved in a car crash'

Daily Mirror

time2 hours ago

  • Daily Mirror

'My seatbelt saved my life - but I wasn't even involved in a car crash'

Natalie Deakin, from Nuneaton, Warwickshire, says she is "really grateful" for her car's seatbelt - because she believes it helped her spot a key symptom of her stage-two Hodgkin Lymphoma A mum says her car seatbelt for saving her life - as the "'irritating" strap led her to discover a cancerous lump hidden in her neck. ‌ When the device began causing Natalie Deakin discomfort on her drive home from the weekly shop, she tried to readjust its position. However, the 34-year-old woman felt a hard lump on the right side of her neck. ‌ And so the mum of two immediately booked an appointment with her GP who ordered a series of tests on the golf ball-sized mass. A CT scan and biopsy then revealed Natalie had Hodgkin Lymphoma - an uncommon cancer which develops in the lymphatic system. ‌ Natalie, who is a hairdresser, said: "Never in a million years did I think I'd be saying I had cancer at 34... I feel like the seat belt has probably factored in saving my life, which is strange. I'm really grateful for it. Things could've been very different for me. "People should be very vigilant over our bodies. Check yourself all the time. If you notice any sort of change and think that's not normal, get it checked out." ‌ Natalie had experienced no symptoms or changes in her health in the lead up to her cancer diagnosis, other than discovering the lump in her neck in her car. The mum, who is due to begin chemotherapy treatment, continued: "Life was normal. I had no symptoms, nothing. There were no changes in my body. I felt very fit and healthy. I didn't have any other symptoms. If I hadn't found the lump, I would've just carried on with life as normal. "I was on my way back from the supermarket after doing the weekly shop and I kept thinking the seatbelt was really irritating my neck. "I moved it away a few times and repositioned it but thought what is it doing? Then all of a sudden, I moved it away from me and touched my neck and felt this big mass in my neck. I just thought what on earth is that? I just remember the fear, anxiety and sickness that went through me." ‌ Cancer Research UK provide details on lymphoma The salon owner, of Nuneaton, Warwickshire, has stage-two Hodgkin Lymphoma. Around 2,100 people are diagnosed with Hodgkin lymphoma in the UK each year, according to the NHS. Typically, swelling in the neck, armpit or groin is an early sign of the cancer. This is caused by an excess of affected lymphocytes (white blood cells) collecting in a lymph node. But in Natalie's case, the lump was her first sign - and she is now imploring others to check their own bodies for any abnormal changes. She added: "I was thinking about my own funeral. It was awful to think that - I didn't think I'd be thinking about that until I was in my 80s. "We had so many wonderful things booked for this year but none of them can go ahead. My life has come to a standstill. How can you live your life normally, go shopping, find a lump and your whole life falls apart in that one second."

Patients to be fast-tracked on to new head and neck cancer vaccine trial
Patients to be fast-tracked on to new head and neck cancer vaccine trial

South Wales Argus

time3 hours ago

  • South Wales Argus

Patients to be fast-tracked on to new head and neck cancer vaccine trial

The first patients have received the jab, which uses mRNA technology to train the immune system to fight cancer, with more set to be enrolled at their nearest NHS hospital. Head and neck cancer is a general term to describe forms of the disease in those regions of the body, and can include cancer of the mouth, throat or voice box. Around 11,000 new cases are diagnosed in England every year. Aggressive forms are difficult to treat, with high rates of recurrence and two-year survival rates under 50%. The vaccine used in the study has been designed to create two proteins that are commonly found in head and neck cancers associated with high-risk types of human papillomavirus (HPV). These types of cancer, known as squamous cell cancers, develop from flat, scale-like cells in the outer layer of the skin and other areas of the body. More than 100 patients with advanced forms of the disease will be matched to the trial, known as AHEAD-MERIT (BNT113), which will run at 15 hospitals over the next year. Health minister Karin Smyth described the plan as a 'massive win for cancer patients'. She added: 'These cancer vaccines could be game-changing for patients facing some of the most challenging diagnoses. 'By getting these trials running in our NHS, we're putting ourselves at the forefront of medical innovation, improving outcomes for people living with cancer.' NHS England has joined forces with life sciences company BioNTech to help identify potentially eligible patients to refer to NHS hospitals running the trial. The trial is the third to be run through the NHS Cancer Vaccine Launch Pad, which is supported by the Cancer Research UK-funded Southampton Clinical Trials Unit. Professor Peter Johnson, national clinical director for cancer at NHS England, said: 'It's fantastic that more patients with advanced head and neck cancers will now be able to access this potentially transformative vaccine, offering renewed hope of holding the disease at bay.' Tamara Kahn, chief executive at Oracle Head & Neck Cancer UK, said the trial 'offers crucial hope to those living with advanced stages of cancer'. 'While we advocate for HPV vaccination to prevent these cancers, those already fighting this devastating disease urgently need new treatments that could mean more time with loved ones,' she added. Chris Curtis was diagnosed with HPV-related head and neck cancer in 2011 and set up a support charity, The Swallows. The 67-year-old, from Blackpool, said: 'As a survivor of HPV-related head and neck cancer, I know first-hand the physical, emotional, and psychological toll this disease takes not just on the patient, but on the entire support system around them. 'With this aggressive cancer you live in the fear of reoccurrence every day – so anything that could help control the disease or give people peace of mind is groundbreaking – it'll allow people to get on with their lives and move forward.' The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer about 550 patients to trials for vaccines for bowel and skin cancers. Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: 'The Cancer Vaccines Launch Pad is an important route to fast-track promising mRNA vaccine technology into clinical trials. 'Research into personalised cancer treatments is vital. 'There are over 200 different types of cancer and it's unlikely there will ever be a single cure that works for everyone. 'That's why it's vital that we support a wide range of research, so that more people can live longer, better lives, free from the fear of cancer.'

Patients to be fast-tracked on to new head and neck cancer vaccine trial
Patients to be fast-tracked on to new head and neck cancer vaccine trial

Leader Live

time3 hours ago

  • Leader Live

Patients to be fast-tracked on to new head and neck cancer vaccine trial

The first patients have received the jab, which uses mRNA technology to train the immune system to fight cancer, with more set to be enrolled at their nearest NHS hospital. Head and neck cancer is a general term to describe forms of the disease in those regions of the body, and can include cancer of the mouth, throat or voice box. Around 11,000 new cases are diagnosed in England every year. Aggressive forms are difficult to treat, with high rates of recurrence and two-year survival rates under 50%. The vaccine used in the study has been designed to create two proteins that are commonly found in head and neck cancers associated with high-risk types of human papillomavirus (HPV). These types of cancer, known as squamous cell cancers, develop from flat, scale-like cells in the outer layer of the skin and other areas of the body. More than 100 patients with advanced forms of the disease will be matched to the trial, known as AHEAD-MERIT (BNT113), which will run at 15 hospitals over the next year. Health minister Karin Smyth described the plan as a 'massive win for cancer patients'. She added: 'These cancer vaccines could be game-changing for patients facing some of the most challenging diagnoses. 'By getting these trials running in our NHS, we're putting ourselves at the forefront of medical innovation, improving outcomes for people living with cancer.' NHS England has joined forces with life sciences company BioNTech to help identify potentially eligible patients to refer to NHS hospitals running the trial. The trial is the third to be run through the NHS Cancer Vaccine Launch Pad, which is supported by the Cancer Research UK-funded Southampton Clinical Trials Unit. Professor Peter Johnson, national clinical director for cancer at NHS England, said: 'It's fantastic that more patients with advanced head and neck cancers will now be able to access this potentially transformative vaccine, offering renewed hope of holding the disease at bay.' Tamara Kahn, chief executive at Oracle Head & Neck Cancer UK, said the trial 'offers crucial hope to those living with advanced stages of cancer'. 'While we advocate for HPV vaccination to prevent these cancers, those already fighting this devastating disease urgently need new treatments that could mean more time with loved ones,' she added. Chris Curtis was diagnosed with HPV-related head and neck cancer in 2011 and set up a support charity, The Swallows. The 67-year-old, from Blackpool, said: 'As a survivor of HPV-related head and neck cancer, I know first-hand the physical, emotional, and psychological toll this disease takes not just on the patient, but on the entire support system around them. 'With this aggressive cancer you live in the fear of reoccurrence every day – so anything that could help control the disease or give people peace of mind is groundbreaking – it'll allow people to get on with their lives and move forward.' The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer about 550 patients to trials for vaccines for bowel and skin cancers. Dr Iain Foulkes, executive director of research and innovation at Cancer Research UK, said: 'The Cancer Vaccines Launch Pad is an important route to fast-track promising mRNA vaccine technology into clinical trials. 'Research into personalised cancer treatments is vital. 'There are over 200 different types of cancer and it's unlikely there will ever be a single cure that works for everyone. 'That's why it's vital that we support a wide range of research, so that more people can live longer, better lives, free from the fear of cancer.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store